RXRX

#2035
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.6 5 USD
+6.73%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
3.50
3.67
Range Annuel
2.77
7.18
Changement quotidien
+6.73%
Changement Mensuel
+9.61%
Evolution sur 6 mois
-18.16%
Changement Annuel
-16.09%
Clôture Précédente
3.4 2
Open
3.5 3
Low
3.5 0
High
3.6 7
Volume
3 029
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 1.93 B
  • Employee 600
  • Founded 2013
  • CEO Najat Khan
  • Website www.recursion.com
  • Headquarter Delaware, United States
  • FIGI BBG00PQ4XJ45
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.84
ratio cours/chiffre d'affaires
24.5

Recursion Pharmaceuticals, Inc. - Class A Common Stock

Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering. The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson.

Nouvelles